Deutsche Bank Ag\ Albireo Pharma, Inc. Transaction History

Deutsche Bank Ag\

$218 Billion
Q2 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$18.01 - $23.78 $738,590 - $975,217	-41,010 Reduced 83.2%	8,278 $178,000
Q3 2022 Nov 14, 2022	SELL	$16.32 - $26.37 $18,670 - $30,167	-1,144 Reduced 2.27%	49,288 $954,000
Q2 2022 Aug 11, 2022	BUY	$18.54 - $37.29 $757,266 - $1.52 Million	40,845 Added 426.05%	50,432 $1 Million
Q1 2022 May 13, 2022	SELL	$23.94 - $33.74 $25,855 - $36,439	-1,080 Reduced 10.12%	9,587 $286,000
Q4 2021 Feb 11, 2022	SELL	$21.19 - $31.29 $356,140 - $525,891	-16,807 Reduced 61.17%	10,667 $248,000
Q3 2021 Nov 04, 2021	SELL	$27.36 - $35.98 $8,508 - $11,189	-311 Reduced 1.12%	27,474 $857,000
Q2 2021 Aug 11, 2021	SELL	$28.9 - $36.87 $24,391 - $31,118	-844 Reduced 2.95%	27,785 $977,000
Q1 2021 May 13, 2021	SELL	$32.03 - $42.85 $32,766 - $43,835	-1,023 Reduced 3.45%	28,629 $1.01 Million
Q4 2020 Feb 16, 2021	SELL	$31.56 - $42.16 $2.32 Million - $3.1 Million	-73,587 Reduced 71.28%	29,652 $1.11 Million
Q3 2020 Nov 12, 2020	SELL	$23.19 - $41.61 $324,358 - $581,999	-13,987 Reduced 11.93%	103,239 $3.45 Million
Q2 2020 Aug 13, 2020	BUY	$14.82 - $29.92 $879,329 - $1.78 Million	59,334 Added 102.49%	117,226 $3.11 Million
Q1 2020 May 14, 2020	BUY	$11.67 - $27.23 $497,643 - $1.16 Million	42,643 Added 279.64%	57,892 $947,000
Q4 2019 Feb 14, 2020	SELL	$16.92 - $28.96 $294,492 - $504,048	-17,405 Reduced 53.3%	15,249 $386,000
Q3 2019 Nov 14, 2019	BUY	$20.0 - $31.88 $130,140 - $207,443	6,507 Added 24.89%	32,654 $650,000
Q2 2019 Aug 14, 2019	BUY	$30.67 - $37.86 $452,719 - $558,851	14,761 Added 129.64%	26,147 $841,000
Q1 2019 May 15, 2019	SELL	$22.22 - $32.21 $11,643 - $16,878	-524 Reduced 4.4%	11,386 $365,000
Q4 2018 Feb 14, 2019	SELL	$20.9 - $32.57 $182,791 - $284,857	-8,746 Reduced 42.34%	11,910 $291,000
Q3 2018 Dec 21, 2021	BUY	$29.29 - $36.87 $70,676 - $88,967	2,413 Added 13.23%	20,656 $680,000
Q3 2018 Nov 14, 2018	SELL	$29.29 - $36.87 $136,872 - $172,293	-4,673 Reduced 20.39%	18,243 $600,000
Q2 2018 Apr 21, 2020	BUY	$28.9 - $37.31 $80,862 - $104,393	2,798 Added 13.91%	22,916 $813,000
Q2 2018 Aug 14, 2018	BUY	$28.9 - $37.31 $578,520 - $746,871	20,018 Added 20018.0%	20,118 $713,000
Q1 2018 May 15, 2018	BUY	$26.78 - $39.35 $2,678 - $3,935	100 New	100 $3,000
Q4 2017 Feb 14, 2018	SELL	$21.56 - $28.14 $1.47 Million - $1.92 Million	-68,060 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$20.44 - $25.65 $1.39 Million - $1.75 Million	68,060	68,060 $1.43 Million

Others Institutions Holding ALBO

# of Institutions

Shares Held

865

Call Options Held

Put Options Held

View Full List

About ALBIREO PHARMA, INC.

Ticker ALBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,612,500
Description
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...

More about ALBO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account